Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Timing matters in budgeting. This section outlines indicators for when to revisit and tweak your budget to reflect new expenses.
18,658 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
The allure of a $16 billion contracted revenue pipeline can blind investors to real dangers. This article breaks down...
Three years can change a company’s story. Explore the signals that will determine MercadoLibre's path, focusing on fi...
NVIDIA’s AI surge is redefining the memory supply chain, and Micron investors face new headwinds. This deep dive expl...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
As AI headlines drive swings in tech stocks, investors ask whether Vanguard's broad tech ETF is the right pick for 20...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
A clear, ground-level view of aecom (acm) 2026 earnings, translating the latest call into actionable takeaways. Learn...
Self-employed workers who filed paper returns in the 1990s may have missing earnings data, risking tens of thousands ...
As AI workloads surge, choosing the right infrastructure partner matters. This guide compares CoreWeave and Nebius, w...